Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FlexiQule MAX is a topical botanical emollient developed by AlchemLife (a division of Alchem International) for the management of joint and muscle pain, stiffness, and inflammation. The formulation features a synergistic blend of phytoactive extracts, primarily Ginger (*Zingiber Officinale*) and *Boswellia Serrata* (Indian Frankincense), which are known to inhibit pro-inflammatory enzymes such as arachidonate 5-lipoxygenase (5-LOX) and prostaglandin-endoperoxide synthase (COX). It also contains Piperine to enhance the bioavailability of the active components, along with other botanical oils including *Celastrus Paniculata*, Lavender, Apricot, and Sunflower oils. Designed for topical application, FlexiQule MAX targets inflammation at the source and helps mitigate cartilage degeneration. While marketed for conditions like arthritis and backaches, it is classified as a natural wellness product or dietary supplement rather than an FDA-approved pharmaceutical.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on FlexiQule MAX.